Pharmacoeconomics refers to the subject that compares the worth of 1 pharmaceutical drug or drug medical aid to a different. It is a sub-discipline of health political economy. A pharmacoeconomic study evaluates the value and effects of a pharmaceutical product. Pharmacoeconomics studies serve to guide best care resource allocation, in a very standardized and scientifically grounded manner. Pharmacoeconomics centers on the economic analysis of prescription drugs, and may use cost-minimization analysis, analytic thinking, cost-effectiveness analysis or cost-utility analysis. Quality-adjusted life years became the dominant outcome of interest in pharmacoeconomic evaluations, and lots of studies use a cost-per-QALY analysis. Economic evaluations area unit dispensed aboard irregular controlled trials and victimization strategies of decision-analytic modeling. Pharmacoeconomics may be a helpful methodology of economic analysis of assorted treatment choices. As dearer medication area unit being developed and authorized its become imperative particularly in context of developing countries wherever resources area unit scarce to use the principles of pharmacoeconomics for numerous medication and treatment choices in order that most improvement in quality of life will be achieved in minimum value. Pharmacovigilance and Pharmacoepidemiology Journal offer a stage in Pharmacoepidemiology Researches and related subjects. Journal accepts leading forefront original research papers, review manuscripts, case reports and commentary in the field. Our target audience, readers and contributors are worldwide.